Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Portage Biotech Inc.

    NASDAQ: PRTG · Real-Time Price · USD
    6.09
    0.10 (1.67%)
    At close: Jun 16, 2025, 3:59 PM
    6.03
    -0.99%
    After-hours: Jun 16, 2025, 04:00 PM EDT

    Portage Biotech Statistics

    Share Statistics

    Portage Biotech has 1.12M shares outstanding. The number of shares has increased by -94.33% in one year.

    Shares Outstanding

    n/a
    		 1.12M

    Shares Change (YoY)

    n/a
    		 -94.33%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 10.71%

    Shares Floating

    n/a
    		 275.06K

    Failed to Deliver (FTD) Shares

    n/a
    		 3,883

    FTD / Avg. Volume

    n/a
    		 0.29%

    Short Selling Information

    The latest short interest is 16.23K, so 0.99% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 16.23K

    Short % of Shares Out

    n/a
    		 0.99%

    Short % of Float

    n/a
    		 1.25%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -2.99 and the forward PE ratio is -0.6. Portage Biotech's PEG ratio is 0.07.

    PE Ratio

    n/a
    		 -2.99

    Forward PE

    n/a
    		 -0.6

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 2.7

    PB Ratio

    n/a
    		 55.93

    P/FCF Ratio

    n/a
    		 -15.74

    PEG Ratio

    n/a
    		 0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Portage Biotech.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 2.67

    Quick Ratio

    n/a
    		 2.67

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 -570.41

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-10,762,714.29

    Employee Count

    n/a
    		 7

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -10.55M

    Effective Tax Rate

    n/a
    		 12.31%

    Stock Price Statistics

    The stock price has increased by 19.4% in the last 52 weeks. The beta is 0.67, so Portage Biotech's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.67

    52-Week Price Change

    n/a
    		 19.4%

    50-Day Moving Average

    n/a
    		 8.08

    200-Day Moving Average

    n/a
    		 5.81

    Relative Strength Index (RSI)

    n/a
    		 33.91

    Average Volume (20 Days)

    n/a
    		 1,347,623

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -54K

    Operating Income

    n/a
    		 -18.25M

    Net Income

    n/a
    		 -75.34M

    EBITDA

    n/a
    		 -18.2M

    EBIT

    n/a
    		 -18.25M

    Earnings Per Share (EPS)

    n/a
    		 -3.7
    Full Income Statement

    Balance Sheet

    The company has 5.03M in cash and 47K in debt, giving a net cash position of 4.98M.

    Cash & Cash Equivalents

    n/a
    		 5.03M

    Total Debt

    n/a
    		 47K

    Net Cash

    n/a
    		 4.98M

    Retained Earnings

    n/a
    		 -239.32M

    Total Assets

    n/a
    		 2.71M

    Working Capital

    n/a
    		 1.81M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -14.3M and capital expenditures 0, giving a free cash flow of -14.3M.

    Operating Cash Flow

    n/a
    		 -14.3M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -14.3M

    FCF Per Share

    n/a
    		 -0.7
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    PRTG does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for PRTG.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 15, 2024. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Aug 15, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -217.08

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist